VLDLR 抗体 (AA 551-650) (PE)
Quick Overview for VLDLR 抗体 (AA 551-650) (PE) (ABIN705561)
抗原
See all VLDLR 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 551-650
-
交叉反应
- 人, 小鼠
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from human VLDL Receptor
-
亚型
- IgG
-
-
-
-
应用备注
- FCM 1:20-100
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- VLDLR (Very Low Density Lipoprotein Receptor (VLDLR))
-
别名
- VLDL Receptor
-
背景
-
Synonyms: CARMQ1, CHRMQ1, VLDLRCH, Very low-density lipoprotein receptor, VLDL receptor, VLDL-R, VLDLR
Background: Binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. Binding to Reelin induces tyrosine phosphorylation of Dab1 and modulation of Tau phosphorylation (By similarity).
-
基因ID
- 7436
-
UniProt
- P98155
-
途径
- Cellular Response to Molecule of Bacterial Origin
抗原
-